52

Titan Biotech LtdBOM 524717 Stock Report

Last reporting period 31 Mar, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.006

Micro

Exchange

XBOM - Bombay Stock Exchange

524717.BO Stock Analysis

52

Uncovered

Titan Biotech Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

89/100

Moderate score

Market cap $B

0.006

Dividend yield

0.52 %

Shares outstanding

8.26 B

Titan Biotech Ltd. is a holding company. The company is headquartered in Delhi, Delhi and currently employs 396 full-time employees. The firm is a manufacturer and exporter of the biological products used in the field of pharmaceuticals, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, microbiology, and others. The firm manufactures peptones, biological extracts, culture media and chemicals. The company offers its products under various categories, such as Food Ingredients, Collagen and Proteins, Pharmaceuticals and Nutraceuticals, Animal Nutrition, Probiotics and Fermentation Ingredients, Agriculture Products, Culture Media and Natures Island. Its Food Ingredients include hydrolyzed vegetable protein (HVP), yeast extract powder, calcium propionate powder, potassium sorbate and calcium lactate. Its Collagen and Proteins include soya protein isolate, collagen peptides, chicken protein isolate, brown rice protein, and others.

View Section: Eyestock Rating